Baseline Patient Characteristics
| Characteristic | Data |
| Age (y) | 64 (55.7–71.0) |
| Sex | |
| Male | 217 (59) |
| Female | 149 (41) |
| Primary tumor | |
| Colorectal cancer | 128 (35.0) |
| Hepatocellular cancer | 57 (15.6) |
| Neuroendocrine tumor | 51 (13.9) |
| Metastatic breast cancer | 40 (10.9) |
| Cholangiocarcinoma | 35 (9.6) |
| Other* | 55 (15.0) |
| Hepatic tumor burden | |
| 25% | 191 (52.2) |
| 25%–50% | 140 (38.3) |
| 50% | 35 (9.6) |
| Extrahepatic disease | |
| Yes | 253 (69.1) |
| No | 113 (30.9) |
| Baseline liver function | |
| Bilirubin (mg/dL) | 0.6 (0.5–0.9) (reference range < 1.2) |
| Cholinesterase (U/L) | 6.35 (4.89–7.6) (reference range > 4.6) |
↵* Pancreas (n = 13), uveal melanoma (n = 6), gastric cancer (n = 6), sarcoma (n = 4), urothelial carcinoma (n = 4), ovarian cancer (n = 3), malignant melanoma (n = 3), cancer of unknown primary (n = 2), prostate cancer (n = 2), lung cancer (n = 2), thymus cancer (n = 2), base-of-tongue cancer (n = 2), squamous cell carcinoma (n = 1), endometrial cancer (n = 1), esophageal carcinoma (n = 1), thyroid carcinoma (n = 1), squamous cell carcinoma of maxillary sinus (n = 1), and testicular cancer (n = 1).
Qualitative data are expressed as numbers followed by percentages in parentheses; continuous data are expressed as median followed by interquartile range in parentheses.